Skip to main content
Top
Published in: Lung 6/2010

01-12-2010

Usefulness of Triglyceride Levels in Pleural Fluid

Authors: Luis Valdés, Ma. Esther San José, Antonio Pose, Juan Carlos Estévez, Francisco J. González-Barcala, José M. Álvarez-Dobaño, Richard W. Light

Published in: Lung | Issue 6/2010

Login to get access

Abstract

The determination of pleural fluid triglycerides (PF-TRIG) is useful in the diagnosis of chylothorax, but its diagnostic value for other causes of pleural effusions is unknown. The aim of this study was to evaluate the usefulness of PF-TRIG in the diagnosis of other pleural effusions and investigate the origin of their increase in these fluids. We studied 390 pleural effusions (75 tuberculous, 107 neoplastic, 39 parapneumonic, 30 miscellaneous, 42 idiopathic, and 97 transudates). The correlation was analyzed with the PF-TRIG values as the dependent variable and serum triglycerides (S-TRIG) and the pleural fluid/serum protein ratio (PF/S PROT ratio) as independent variables. The PF-TRIG was significantly higher in exudates. The sensitivity of PF-TRIG for identifying exudates was 84.3%, specificity 61.9%. The correlation between PF-TRIG and S-TRIG was significant in the exudates and in the total pleural effusions. There was a significant correlation between PF-TRIG and S-TRIG and capillary permeability, which worsened when looking at the transudates and exudates separately. No correlations were found between the PF-TRIG and the number of red cells and white cells in any of the groups. Except for diagnosing a chylothorax, the determination of triglycerides in pleural fluid does not appear to be justified. The cause of the increase in PF-TRIG in exudates could not be established because the correlations obtained were insufficient to be able to predict PF-TRIG values from their serum values and the measurement of capillary permeability.
Literature
1.
go back to reference Collins TR, Sahn SA (1987) Thoracentesis: complications, patient experience and diagnostic value. Chest 91:817–822CrossRefPubMed Collins TR, Sahn SA (1987) Thoracentesis: complications, patient experience and diagnostic value. Chest 91:817–822CrossRefPubMed
2.
go back to reference Sahn SA (1987) Pleural fluid analysis: narrowing the differential diagnosis. Semin Respir Med 9:22–29CrossRef Sahn SA (1987) Pleural fluid analysis: narrowing the differential diagnosis. Semin Respir Med 9:22–29CrossRef
3.
go back to reference Sahn SA (1988) The pleura. State of the art. Am Rev Respir Dis 138:184–234PubMed Sahn SA (1988) The pleura. State of the art. Am Rev Respir Dis 138:184–234PubMed
4.
go back to reference Gopi A, Madhavan SM, Sharma SK, Sahn SA (2007) Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 131:880–889CrossRefPubMed Gopi A, Madhavan SM, Sharma SK, Sahn SA (2007) Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 131:880–889CrossRefPubMed
5.
go back to reference Valdés L, Álvarez D, San José E, Juanatey JR, Pose A, Valle JM, Salgueiro M, Suarez JR (1995) Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis. Thorax 50:593–594CrossRef Valdés L, Álvarez D, San José E, Juanatey JR, Pose A, Valle JM, Salgueiro M, Suarez JR (1995) Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis. Thorax 50:593–594CrossRef
6.
go back to reference Valdés L, Álvarez D, Valle JM, Pose A, San José E (1996) The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest 109:158–162CrossRefPubMed Valdés L, Álvarez D, Valle JM, Pose A, San José E (1996) The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest 109:158–162CrossRefPubMed
7.
go back to reference Hamm H, Pfalzer B, Fabel H (1991) Lipoprotein analysis in a chyliform pleural effusion: implications for pathogenesis and diagnosis. Respiration 58:294–300CrossRefPubMed Hamm H, Pfalzer B, Fabel H (1991) Lipoprotein analysis in a chyliform pleural effusion: implications for pathogenesis and diagnosis. Respiration 58:294–300CrossRefPubMed
8.
go back to reference Valdés L, Pose A, Suárez J, Gonzalez-Juanatey JR, Sarandeses A, San José E, Alvarez Dobaña JM, Salgueiro M, Rodríguez Suárez JR (1991) Cholesterol: a useful parameter for distinguishing between pleural exudates and transudates. Chest 99:1097–1102CrossRefPubMed Valdés L, Pose A, Suárez J, Gonzalez-Juanatey JR, Sarandeses A, San José E, Alvarez Dobaña JM, Salgueiro M, Rodríguez Suárez JR (1991) Cholesterol: a useful parameter for distinguishing between pleural exudates and transudates. Chest 99:1097–1102CrossRefPubMed
9.
go back to reference Costa M, Quiroga T, Cruz E (1995) Measurement of pleural fluid cholesterol and lactate dehydrogenase. A simple and accurate set of indicators for separating exudates from transudates. Chest 108:1260–1263CrossRefPubMed Costa M, Quiroga T, Cruz E (1995) Measurement of pleural fluid cholesterol and lactate dehydrogenase. A simple and accurate set of indicators for separating exudates from transudates. Chest 108:1260–1263CrossRefPubMed
10.
go back to reference Valdés L, Pose A, San José E, Suarez J, Penela P, Valle JM, Alvarez D (1998) Diagnostic value of cholesterol in pleural fluids. Eur J Intern Med 9:157–164 Valdés L, Pose A, San José E, Suarez J, Penela P, Valle JM, Alvarez D (1998) Diagnostic value of cholesterol in pleural fluids. Eur J Intern Med 9:157–164
11.
go back to reference Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K (1980) The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55:700–704PubMed Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K (1980) The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55:700–704PubMed
12.
go back to reference Sahn SA, Heffner JE (2003) Pleural fluid analysis. In: Light RW, Lee YCG (eds) Textbook of pleural fluids. Arnold, London, pp 191–209 Sahn SA, Heffner JE (2003) Pleural fluid analysis. In: Light RW, Lee YCG (eds) Textbook of pleural fluids. Arnold, London, pp 191–209
13.
go back to reference Mahley RW, Weisgraber KW, Farese RV Jr (1998) Disorders of lipid metabolism. In: Williams RH (ed) Williams textbook of endocrinology. WB Saunders, Philadelphia, pp 1099–1119 Mahley RW, Weisgraber KW, Farese RV Jr (1998) Disorders of lipid metabolism. In: Williams RH (ed) Williams textbook of endocrinology. WB Saunders, Philadelphia, pp 1099–1119
14.
go back to reference Meisel S, Shamiss A, Thaler M, Nussinovitch N, Rosenthal T (1990) Pleural fluid to serum bilirubin concentration ratio for the separation of transudates from exudates. Chest 98:141–144CrossRefPubMed Meisel S, Shamiss A, Thaler M, Nussinovitch N, Rosenthal T (1990) Pleural fluid to serum bilirubin concentration ratio for the separation of transudates from exudates. Chest 98:141–144CrossRefPubMed
15.
go back to reference Roth BJ, O’Meara TF, Cragum WH (1990) The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest 98:546–549CrossRefPubMed Roth BJ, O’Meara TF, Cragum WH (1990) The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest 98:546–549CrossRefPubMed
16.
go back to reference Heffner JE, Brown LK, Barbieri C (1997) Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Chest 111:970–979CrossRefPubMed Heffner JE, Brown LK, Barbieri C (1997) Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Chest 111:970–979CrossRefPubMed
17.
go back to reference Romero S, Candela A, Martin C, Hernández L, Trigo C, Gil J (1993) Evaluation of different criteria for the separation of pleural transudates from exudates. Chest 104:399–404CrossRefPubMed Romero S, Candela A, Martin C, Hernández L, Trigo C, Gil J (1993) Evaluation of different criteria for the separation of pleural transudates from exudates. Chest 104:399–404CrossRefPubMed
18.
go back to reference Burgess L, Maritz FJ, Taljaard JJF (1995) Comparative analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest 107:1604–1609CrossRefPubMed Burgess L, Maritz FJ, Taljaard JJF (1995) Comparative analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest 107:1604–1609CrossRefPubMed
19.
go back to reference Antony VB, Holm KA (1995) Testing the waters. Differentiating transudates from exudates. Chest 108:1191–1192CrossRefPubMed Antony VB, Holm KA (1995) Testing the waters. Differentiating transudates from exudates. Chest 108:1191–1192CrossRefPubMed
20.
go back to reference Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH (2009) Pleural fluid characteristics of chylothorax. Mayo Clin Proc 84:129–133CrossRefPubMed Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH (2009) Pleural fluid characteristics of chylothorax. Mayo Clin Proc 84:129–133CrossRefPubMed
21.
go back to reference Sahn SA (1995) Diagnostic value of pleural fluid analysis. Semin Respir Crit Care Med 6:269–278CrossRef Sahn SA (1995) Diagnostic value of pleural fluid analysis. Semin Respir Crit Care Med 6:269–278CrossRef
22.
go back to reference Vaz MA, Teixeira LR, Vargas FS, Carmo AO, Antonangelo L, Onishi R, Light RW (2001) Relationship between pleural fluid and serum cholesterol levels. Chest 119:204–210CrossRefPubMed Vaz MA, Teixeira LR, Vargas FS, Carmo AO, Antonangelo L, Onishi R, Light RW (2001) Relationship between pleural fluid and serum cholesterol levels. Chest 119:204–210CrossRefPubMed
23.
go back to reference Valdés L, San-José E, Estévez JC, González-Barcala FJ, Álvarez-Dobaño JM, Golpe A, Valle JM, Penela P, Vizcaíno L, Pose A (2010) Cholesterol in pleural exudates depends mainly on increased capillary permeability. Transl Res 155:178–184CrossRefPubMed Valdés L, San-José E, Estévez JC, González-Barcala FJ, Álvarez-Dobaño JM, Golpe A, Valle JM, Penela P, Vizcaíno L, Pose A (2010) Cholesterol in pleural exudates depends mainly on increased capillary permeability. Transl Res 155:178–184CrossRefPubMed
24.
go back to reference Hillerdal G (2003) Effusions from lymphatic disruptions. In: Light RW, Lee YCG (eds) Textbook of pleural diseases. Arnold, London, pp 362–369 Hillerdal G (2003) Effusions from lymphatic disruptions. In: Light RW, Lee YCG (eds) Textbook of pleural diseases. Arnold, London, pp 362–369
Metadata
Title
Usefulness of Triglyceride Levels in Pleural Fluid
Authors
Luis Valdés
Ma. Esther San José
Antonio Pose
Juan Carlos Estévez
Francisco J. González-Barcala
José M. Álvarez-Dobaño
Richard W. Light
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Lung / Issue 6/2010
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-010-9261-4

Other articles of this Issue 6/2010

Lung 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.